Michael Grey
Equibles does not estimate personal net worth.
Get an email with a short summary when Mirum Pharmaceuticals, Inc. publishes a filing, an earnings call transcript or a press release.
Get MIRM alertsAbout Michael Grey
Michael Grey is recorded as CEO at Mirum Pharmaceuticals, Inc. (MIRM). The proxy statement of Mirum Pharmaceuticals, Inc. reports total compensation of $5,662,396 for Michael Grey in fiscal 2019, including a base salary of $300,000. Disclosed compensation is on record for 2 fiscal years. Mirum Pharmaceuticals, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Mirum Pharmaceuticals, Inc. includes Christopher Peetz (CEO), Eric Bjerkholt (CFO), Peter Radovich (COO) and 5 others.
Affiliation history
-
Current
Company network
Leadership on record at Mirum Pharmaceuticals, Inc.
- Christopher Peetz CEO
- Eric Bjerkholt CFO
- Peter Radovich COO
- Lon Cardon, Ph.D., FMedSci Board Member
- Saira Ramasastry Board Member
- Timothy Walbert Board Member
- To approve Board Member
- William Fairey Board Member
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2019 | Mirum Pharmaceuticals, Inc. (MIRM) | Former Executive Chairman and Chief Executive Officer | $300,000 | $5,662,396 |
| 2018 | Mirum Pharmaceuticals, Inc. (MIRM) | Former Executive Chairman and Chief Executive Officer | $25,000 | $25,000 |
Recent activity
No call appearances or filed executive changes recorded yet.